Provided by Tiger Trade Technology Pte. Ltd.

X4 Pharmaceuticals Inc

4.05
+0.01000.25%
Volume:299.17K
Turnover:1.21M
Market Cap:401.54M
PE:-3.27
High:4.10
Open:4.03
Low:3.94
Close:4.04
52wk High:4.83
52wk Low:2.80
Shares:99.15M
Float Shares:62.35M
Volume Ratio:0.41
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2404
EPS(LYR):-1.8726
ROE:-113.08%
ROA:-28.15%
PB:2.58
PE(LYR):-2.16

Loading ...

Jan 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 23, 2024

Correspondence

Form CORRESP - Correspondence
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Oct 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 04, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 16, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]